ZYDUSLIFE Zydus Lifesciences Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens ZYDUSLIFE is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about ZYDUSLIFE
In the last completed session, Zydus Lifesciences Ltd. closed +1.20% with futures open interest moving +1.6%. That combination — price rising while OI builds — is classified as a Long Buildup, meaning derivative traders are adding fresh bullish positions into strength rather than merely covering existing shorts. The option PCR of 0.86 is balanced — no clear directional preference from option writers.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Zydus Lifesciences Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Zydus Lifesciences Ltd. leans constructive into the next session.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-08-25 · spot 1,114 · EOD 2026-08-07
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 35%
Δ 0.80
θ -0.8
ν 1
|
1050 |
IV 32%
Δ -0.17
θ -0.5
ν 1
|
|
IV 16%
Δ 0.94
θ -0.3
ν 0
|
1060 |
IV 31%
Δ -0.20
θ -0.6
ν 1
|
|
IV 56%
Δ 0.66
θ -1.6
ν 1
|
1070 |
IV 31%
Δ -0.25
θ -0.6
ν 1
|
|
IV 36%
Δ 0.68
θ -1.0
ν 1
|
1080 |
IV 30%
Δ -0.29
θ -0.7
ν 1
|
|
IV 55%
Δ 0.61
θ -1.6
ν 1
|
1090 |
IV 30%
Δ -0.34
θ -0.7
ν 1
|
|
IV 34%
Δ 0.60
θ -1.1
ν 1
|
1100 S |
IV 30%
Δ -0.39
θ -0.7
ν 1
|
|
IV 34%
Δ 0.55
θ -1.1
ν 1
|
1110 MP |
IV 30%
Δ -0.45
θ -0.7
ν 1
|
|
IV 34%
Δ 0.50
θ -1.1
ν 1
|
1120 |
IV 30%
Δ -0.50
θ -0.7
ν 1
|
|
IV 34%
Δ 0.45
θ -1.0
ν 1
|
1130 |
IV 29%
Δ -0.56
θ -0.7
ν 1
|
|
IV 34%
Δ 0.41
θ -1.0
ν 1
|
1140 R |
IV 30%
Δ -0.61
θ -0.7
ν 1
|
|
IV 34%
Δ 0.36
θ -1.0
ν 1
|
1150 |
IV 30%
Δ -0.66
θ -0.6
ν 1
|
|
IV 34%
Δ 0.32
θ -0.9
ν 1
|
1160 |
IV 25%
Δ -0.75
θ -0.4
ν 1
|
|
IV 30%
Δ 0.25
θ -0.7
ν 1
|
1170 |
IV 48%
Δ -0.65
θ -1.1
ν 1
|
Chain Interpretation
Strategy Builder multi-leg payoff for ZYDUSLIFE options · 2026-08-25 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
ZYDUSLIFE — frequently asked questions
What is the Zydus Lifesciences Ltd. share price today?
ZYDUSLIFE is trading at ₹1,114.20 (+0.56% vs previous close), per the latest update on this page.
What is the P/E ratio of Zydus Lifesciences Ltd.?
ZYDUSLIFE (Zydus Lifesciences Ltd.) has a trailing twelve-month P/E ratio of 22.2.
What is the market cap of Zydus Lifesciences Ltd.?
ZYDUSLIFE has a market capitalisation of approximately ₹111,142 crore.
What is the ROE of Zydus Lifesciences Ltd.?
ZYDUSLIFE has a return on equity (ROE) of about 18.3%.
Is ZYDUSLIFE near its 52-week high?
ZYDUSLIFE is trading -5.7% from its 52-week high of ₹1,181.50 as of 2026-08-07.
What is the RSI of ZYDUSLIFE?
The 14-day RSI of ZYDUSLIFE is 48.3, which is considered neutral.
Is ZYDUSLIFE above its 200-day moving average?
ZYDUSLIFE is trading above its 200-DMA of ₹974.82 (+14.3% away).
What is the F&O buildup in ZYDUSLIFE?
The latest end-of-day derivatives data classifies ZYDUSLIFE as Long Buildup (bias: bullish), based on the day's combined price and open-interest change.
What is the max pain and PCR for ZYDUSLIFE options?
ZYDUSLIFE's option-chain max pain strike is ₹1,110 and its put-call ratio (OI) is 0.86, from the latest end-of-day option chain.
Are FIIs or big investors buying ZYDUSLIFE?
Strota tracks every bulk and block deal in ZYDUSLIFE with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.